Therapeutic Solutions International CEO Issues Shareholder

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
282
Therapeutic Solutions International CEO Issues Shareholder Letter

OCEANSIDE, Calif., Dec. 31, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Therapeutics Solutions International, Inc., ( OTC Markets: TSOI ) addresses shareholders in letter form.

We have had a whirlwind of a year in discovery and amazement at TSOI and we are optimistic for the coming year. I thought I would address just some of the major accomplishments this year brought.

In May of this year, President Donald J. Trump signed into law the "Right To Try" Act and TSOI responded by announcing we would move to offer our immunotherapy platform "StemVacs." We were also honored to appoint Dr. James Veltmeyer as Chief Medical Officer to head up all of our RTT programs.

During the spring and summer, we conducted two small studies of NanoStilbene, our nanoparticle pterostilbene product. One was a pharmacokinetic study comparing NanoStilbene (a liquid form) with traditional powder form pterostilbene. We took two groups of healthy volunteers and gave one group 300 milligrams (mg) in capsule form and the other group 10 milliliters of NanoStilbene which also contains 300mg of nanoparticle pterostilbene and studied their blood across time. We were pleased to see that compared to powder, NanoStilbene at peak blood concentration was 55% greater than the powder form at its peak, and even more pleased at the half-life being double of powder.

In a second clinical study of NanoStilbene in advanced cancer patients, we sought to determine whether administration of our nanoparticle formulation of pterostilbene may reverse cancer associated suppression of NK cell (natural killer cell) activity. We concluded that study mid-summer using the same dose as was used pharmacokinetically and we are currently preparing to submit our manuscript for publication in a medical journal validating NanoStilbene as an adjuvant to chemo and immunotherapy.

We also filed 3 additional provisional patent applications on the use of pterostilbene during the summer. These were a direct result of the data that came back from our advanced cancer study. One of those patents is for Car-T Cell sickness or Cytokine Release Syndrome. Car-T is one of the most advanced FDA approved immunotherapies on the market. Our data from the cancer study supports the use of NanoStilbene to suppress the cytokine storm of Car-T sickness.

We were also greatly honored when Wes Chandler of NFL fame brought to our attention Chronic Traumatic Encephalopathy or CTE, a condition that affects sports players and others who receive repetitive concussions and head injuries. We quickly formed a CTE advisory board with Wes as Chairman to explore CTE and have since filed two CTE related patents. One for prevention of CTE we call NeuroStilbene and one for therapeutic treatment of CTE with enhanced stem cells.

Next on the CTE project was to find a cellular product that would qualify under "Right To Try" and we found that product in the form of mesenchymal stem cells. On Dec 10 we announced licensing of the Jadi Cell universal donor adult stem cell for use in Chronic Traumatic Encephalopathy (CTE), and Traumatic Brain Injury (TBI). Our intent is to have these cells available in early 2019 under RTT.

I know there are many moving parts at TSOI and some of it is years away like the 9,682,047 patent was in July 2015 when we filed, but here we are wrapping up 2018 with a human validated and a patent granted product, NanoStilbene. Looking to 2019 the key things you will see from us will be the promotion of NanoStilbene and NeuroStilbene and the "Right To Try" use of stem cells and eventually our dendritic cell vaccine for cancer, StemVacs.

A Special Thank You to my science and medical team for all of their hard work this past year and for the hard work left ahead of us that they are committed to. We are looking forward to 2019 as an important year for TSOI and we thank all of you for your patience and wish you a Happy New Year from everyone at TSOI. For a more detailed release visit us on https://www.facebook.com/tsoihome/

Sincerely yours,

Tim G Dixon, President & CEO

About Therapeutic Solutions International, Inc. Therapeutic Solutions International is focused on immune modulation for the treatment of several specific diseases. Immune modulation refers to the ability to upregulate (make more active) or downregulate (make less active) one's immune system. The Company's corporate website is www.therapeuticsolutionsint.com .

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Safe Harbor Statement This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous risk factors as set forth in our SEC filings. To the extent that statements in this press release are not strictly historical, including statements as to product launch timing, revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future collaboration agreements, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made.

  Contact Information:

Therapeutic Solutions International, Inc. ir@tsoimail.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MERSCO’s Holiday Push Tests Backyard Play Demand in 2026

Updated Category News Views 103

A trampoline sale is not exactly a macroeconomic bellwether, but it does expose a useful little corner of holiday spending: parents buying big, awkward, discretionary stuff that has to earn its space in the yard. MERSCO is joining Amazon’s Black Friday and Cyber Monday window from November 19 through November 30, 2026, with discounts reaching 38% on selected products....

Continue Reading
Blast Doubles Athabasca Ground, but Drills Still Matter

Updated Category News Views 0

More ground in Athabasca can wake up a uranium junior fast, and Blast Resources has certainly grabbed investors’ attention with this one. The company has optioned eight additional uranium claims beside its Wales Lake property in northern Saskatchewan, taking its regional footprint from 12,150 hectares across 16 claims to 30,732 hectares across 24 claims. That is more...

Continue Reading
PSEG Long Island Warns Customers on QR Payment Scams

Updated Category News Views 131

Holiday panic is a thief's favorite crowbar, and Long Island households are plainly in the crosshairs. PSEG Long Island used Utility Scam Awareness Day on Nov. 18 to warn customers about impersonators demanding immediate payment under threat of a power shutoff. The central message, “Think Before You Scan,” is not flashy corporate wallpaper. It is practical advice for...

Continue Reading
First US Extends Buyback Clock Through Year-End 2027

Updated Category News Views 188

A buyback extension is not a thunderclap; it is a bank board keeping a useful tool within reach. First US Bancshares has pushed the expiration of its existing repurchase authorization from December 31, 2026, to December 31, 2027. That matters, but investors ought to resist turning a calendar change into a grand earnings prophecy. The company has bought back 2,122,972...

Continue Reading
GE Aerospace Backs Service Members With $100K Gift

Updated Category News Views 190

A six-figure commitment can look tiny beside jet-engine budgets, yet it can matter a great deal when it reaches people navigating the awkward jump from military service into civilian life. GE Aerospace has committed $100,000 to Embry-Riddle Aeronautical University to support transitioning service members. That is the whole heart of this announcement, and frankly, it is...

Continue Reading
Aimbient's OR Timestamp Study Puts Efficiency to Test

Updated Category News Views 160

A camera catching a patient’s arrival on time may sound mundane, but operating rooms are where mundane details can turn into serious money and better operational decisions. Aimbient’s newly corrected announcement points to an independently conducted Stanford Medicine study in JAMA Surgery that tested whether its computer-vision system could document key operating-room...

Continue Reading
Automotive Laminates: Small Market, Real EV Leverage

Updated Category News Views 126

Cabin trim has become a surprisingly serious battleground, and that is the whole point of this automotive laminates story. Nobody buys a vehicle because somebody bragged about a multilayer film behind the door panel. Yet the materials under the fingertips, beneath the carpet, and around the dashboard increasingly decide whether an interior feels cheap, quiet, durable, or...

Continue Reading
Early Therapy After Sports Injuries Deserves Careful Timing

Updated Category News Views 27

A limp can become a bad habit long before an athlete calls it one. That is the plain, useful concern behind Dr. Kali Spoto LaRue's discussion of sports-injury physical therapy for athletes in Fairport and Greater Rochester. The central message is not that every sore muscle needs the same response, nor that anybody should charge back into practice because they had one...

Continue Reading
FAA Funding Gridlock Raises Aviation Reliability Risk

Updated Category News Views 8

Friday’s radar and communications trouble delivered the sort of warning nobody in aviation can shrug off: the machinery behind the flight board is getting old, fragile, and far too dependent on people improvising around it. Thousands of flights were delayed or canceled when air traffic control facilities became unstable, according to the Southwest Airlines Pilots...

Continue Reading
Schloss Johannisberg Leads 2026 Global Vineyard List

Updated Category News Views 135

A 1,200-year-old riesling estate just beat the world at being memorable. Schloss Johannisberg in Germany’s Rheingau has taken No. 1 in The 50 Best Vineyards 2026, moving up from No. 2 last year and also claiming Best Vineyard in Europe. For anyone watching the wine business from the outside, this is not really a story about one bottle edging out another. It is a...

Continue Reading

Top 5 Most Recently Viewed Articles

NN, Inc. Welcomes Tim Erro as Chief Commercial Officer

Updated Category News Views 219

NN, Inc. Welcomes Tim Erro as Chief Commercial Officer NN, Inc. (NASDAQ: NNBR), a leader in high-precision industrial components, has recently appointed Tim Erro as its new Chief Commercial Officer. In this role, Mr. Erro will spearhead NN's global commercial efforts, enhancing the company's strategic initiatives aimed at business growth and development. Under the...

Continue Reading
Horizon Robotics Unveils Innovations in Smart Driving Solutions

Updated Category News Views 321

Horizon Robotics Unveils Innovations at IAA Mobility 2025 Horizon Robotics, a pioneer in smart driving solutions for passenger vehicles, recently demonstrated its cutting-edge technologies at IAA Mobility 2025. This platform not only highlights the company's dedication to smart mobility but also marks a significant step in its global outreach by establishing new...

Continue Reading
Nuvoton Technology Unveils Exciting New Industrial ICs

Updated Category News Views 157

Nuvoton Technology's Innovative BM-ICs for Industrial Applications Nuvoton Technology Corporation Japan (NTCJ) is set to introduce groundbreaking industrial battery monitoring integrated circuits (BM-ICs) designed for 48V batteries. These new products, named "KA49701A" and "KA49702A," are scheduled to enter mass production soon. Enhanced Safety Features in Battery System...

Continue Reading
Celebrate National Coffee Day with Atlas Coffee Club's Free Offer

Updated Category News Views 206

Celebrate National Coffee Day with Atlas Coffee Club Atlas Coffee Club is thrilled to celebrate National Coffee Day with a fantastic offer that every coffee lover is sure to appreciate. From now until October 2, you can snag a complimentary 12-ounce bag of single-origin coffee just by subscribing. All you need to do is cover the shipping fee, and you’re all set! The...

Continue Reading
Crypto Market Dynamics: Bitcoin and XRP Show Potential Gains

Updated Category News Views 264

Bitcoin Approaches Key Resistance Levels Recently, Bitcoin has seen a substantial surge as it has crossed a significant resistance level around $102,000, signifying a bullish sentiment in the market. This progression highlights a critical test as Bitcoin now looks to penetrate a key psychological and technical barrier at $105,000. The macroeconomic backdrop is favorable,...

Continue Reading